Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients

Ítems similars

• Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma
  per: Matsue, Kosei, et al.
  Publicat: (2018)
• N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma
  per: Abe, Yoshiaki, et al.
  Publicat: (2019)
• Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma
  per: Kobayashi, Hiroki, et al.
  Publicat: (2020)
• Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years
  per: Matsue, Kosei, et al.
  Publicat: (2019)
• Left ventricular diastolic function as a possible predictor of severe carfilzomib-induced cardiovascular events
  per: Abe, Yoshiaki, et al.
  Publicat: (2019)